Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYour real questions about getting weight loss injections on the NHS, answered
Can you get weight loss injections on the NHS right now?
Yes, but far fewer people qualify than the headlines suggest. The main NHS weight loss injection being rolled out in England is tirzepatide, sold as Mounjaro. NHS England is releasing it in stages, following NICE's appraisal of tirzepatide (TA1026), so that the people at highest clinical risk are treated first.
As things stand in mid-2026, two groups can be considered. The first phase, live since June 2025, covers adults with a BMI of 40 or more who also have four or more of five weight-related conditions. The second phase, activated on 23 June 2026, brings in adults with a BMI between 35 and 39.9 who also have four or more of those conditions. A further phase, expected around March 2027, is set to include BMI of 40 or more with three conditions.
The five qualifying conditions are high blood pressure, raised cholesterol or blood fats, obstructive sleep apnoea, cardiovascular disease and type 2 diabetes. For some ethnic backgrounds, the BMI thresholds sit 2.5 kg/m² lower under UK guidance.
One quick habit before you assume you don't qualify: dig out your last blood pressure and cholesterol readings, because many people have more of these conditions logged than they realise. If you're weighing up NHS versus other routes, our overview of weight loss injection options lays out the picture plainly.
What are the NHS criteria for weight loss injections in the UK?
The eligibility rules come straight from NICE and NHS England, and they are stricter than the private licence. For tirzepatide, it's not enough to have a high BMI on its own. You need both the qualifying BMI and the required number of weight-related conditions from the list, and the exact combination depends on which rollout phase is active in your area.
Wegovy runs on a separate track. Under NICE's guidance on semaglutide (TA875), it's recommended only within a specialist weight management service, for a maximum of two years, for adults with at least one weight-related condition and a BMI of 35 or above (or 30 to 34.9 who meet specialist-referral criteria). NHS England quotes lower figures of 32.5 and 27.5 to 32.4 for some ethnic backgrounds.
Meeting the numbers still doesn't guarantee treatment. A clinician assesses the whole picture, and every NHS patient is expected to take part in wrap-around diet and activity support alongside the medicine. If you want the specific numbers broken down, our page on the NHS criteria for weight loss injections walks through each phase, and there's a companion piece on the BMI thresholds the NHS uses.
How do you actually get a weight loss injection on the NHS?
From 1 April 2026, GP practices in England may prescribe tirzepatide under the new GP contract, folded into the QOF framework for 2026/27. That's a genuine shift, because for a while access ran only through specialist clinics. The catch is that participation is optional. Some practices have signed up, some haven't yet, and availability differs from one area and one integrated care board to the next.
In practice, the route usually starts with a conversation with your GP about your weight, your BMI and any related conditions. If you appear to meet the active phase's criteria, and your practice is taking part, you may be started on treatment with the required support built in. Where the GP route isn't open, referral to a specialist weight management service is the alternative, particularly for Wegovy.
Waiting can be the sticking point. Specialist service lists are commonly long, and not every region has capacity. If you'd like the step-by-step version, we've set it out in detail on how to get a weight loss injection on the NHS, and there's a broader guide covering both NHS and other routes at how to get weight loss injections. Scotland, Wales and Northern Ireland set their own criteria, so if you're outside England the specifics will differ.
Why doesn't everyone who's overweight qualify on the NHS?
This is the frustration we hear most often. You've read that these medicines produce real weight loss, your BMI is well over 30, and yet the NHS says no. The reason is capacity and prioritisation, not doubt about whether the treatment works.
NICE recommends tirzepatide, but NHS England has to fund it within a finite budget, so it's being released to the highest-risk groups first and widened over roughly three years. Someone with a BMI of 32 and no other conditions is real and deserving, but under the current phased rollout they sit outside the door for now. The private licence is broader: adults with a BMI of 30 or more, or 27 or above with at least one weight-related condition. That gap between the licence and NHS funding is exactly where a lot of people find themselves stuck.
It helps to see the NHS rules as a rationing decision rather than a clinical verdict on you. The medicine could be suitable for you and still be unavailable through the NHS this year. If you're trying to work out where you stand, our page on who can get weight loss injections on the NHS maps the phases against real situations, and whether you can get them on the NHS at all tackles the borderline cases.
Which weight loss injections are on the NHS, and what's new?
Two injections matter for NHS weight management. Tirzepatide (Mounjaro), made by Eli Lilly, is a once-weekly injection that acts on two gut-hormone receptors, GIP and GLP-1, to reduce appetite and slow how quickly the stomach empties. In the SURMOUNT-1 trial, average body-weight reduction was around 20 to 21% at the top dose over 72 weeks, which you can read about via the NHS medicines page for tirzepatide.
Semaglutide (Wegovy), from Novo Nordisk, is also once-weekly and works on the single GLP-1 pathway. A higher 7.2mg maintenance dose was approved by the MHRA in 2026, with trials reporting around 20.7% average weight loss over 72 weeks, narrowing the gap with tirzepatide.
What tends to confuse people is the newer options in the news. A page on the newest weight loss injections and the NHS keeps track of what's genuinely being rolled out versus what's simply been licensed. Being licensed by the MHRA and being funded by the NHS are two different milestones, and a medicine can clear the first long before the second. Note that Ozempic, though also semaglutide, is licensed for type 2 diabetes rather than weight loss, so it isn't an NHS weight loss injection.
Are NHS weight loss injections free, and what about side effects?
When you're treated on the NHS, the injection itself is free at the point of use, subject to the usual prescription charge rules in your nation. That's a real saving. The trade-off is the strict eligibility and the wait, which is the honest cost most people actually pay. We cover the money side plainly on whether NHS weight loss injections are free.
On safety, the common side effects are gastrointestinal: feeling sick, being sick, loose or hard stools, indigestion, burping, along with tiredness, headaches and reactions where you inject. These are usually most noticeable when you start or step up a dose, and often ease within a couple of weeks.
There's one more serious signal worth knowing. In January 2026 the MHRA issued a Drug Safety Update flagging acute pancreatitis as an uncommon but potentially serious side effect of GLP-1 medicines. If you get severe, persistent stomach pain that spreads to your back, with or without vomiting, seek urgent medical help. Whether NHS-prescribed or private, these are prescription-only medicines that need proper clinical oversight, which is why our page on how safe NHS weight loss injections are goes deeper.
If the NHS says no, what are your options?
Not qualifying for NHS treatment, or facing a long specialist wait, doesn't mean the door is shut. Because the private licence is broader than NHS funding, a regulated UK online pharmacy is a legitimate alternative for people who fall into that gap, and our guide to where you can get weight loss injections covers both NHS and private routes so you can see which realistic options are open to you. The key word is regulated: any pharmacy you use should be verifiable on the General Pharmaceutical Council register, and every legitimate route involves a real clinical assessment before treatment.
This is where nume comes in. We're a clinician-led service with our own GPhC-registered pharmacy, and every consultation is read the same day by a registered Independent Prescriber, never by software. If treatment is clinically suitable, it's dispatched the same working day and delivered free the next working day. If you want to understand that side, our guide to private weight loss injections is the honest starting point, and you can see current treatment pricing on our weight loss treatments hub.
A word of caution that matters more here than anywhere. The MHRA has repeatedly warned about counterfeit weight loss pens sold online and via social media, some containing insulin, and enforcement has seized around 20 million doses. Steer clear of any seller offering these medicines without a clinical assessment. That single check on the GPhC register takes under a minute and is the best protection you have.
Related questions we've answered
Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.